Lars Rombo

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Anthony L. Cunningham, Himal Lal, Martina Kovac et al. · New England Journal of Medicine · 2016 · 1K citations · Full text

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee et al. · The Lancet Infectious Diseases · 2019 · 242 citations

Vaccination, Vaccine Safety, Vaccinology +11

Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study

Roman Chlíbek, Jan Smetana, Karlis Pauksens et al. · Vaccine · 2014 · 133 citations

Vaccinology, Vaccination, Vaccine Safety +9

Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults

Roman Chlíbek, Karlis Pauksens, Lars Rombo et al. · Vaccine · 2015 · 121 citations · Full text

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Céline Boutry, Andrew Hastie, Javier Díez‐Domingo et al. · Clinical Infectious Diseases · 2021 · 90 citations · Full text